Abstract

Differential identification of PT‐VWD from type 2B VWD and <i>GP1BA</i> nomenclature issues response to Othman

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Reply
Kenneth A Arndt ... Murad Alam
Journal of the American Academy of Dermatology | VOL. 67
Kenneth A Arndt, et. al.Kenneth A Arndt ... Murad Alam
01 Oct 2012
Diphasiastrum ×issleri (Lycopodiaceae) in England and Wales
Hazel Metherell ... Chris Metherell
British &amp; Irish Botany | VOL. 3
Hazel Metherell, et. al.Hazel Metherell ... Chris Metherell
16 Feb 2021
(2942) Proposal to conserve the name Dicksonia bipinnata (Dennstaedtia bipinnata, Mucura bipinnata) (Dennstaedtiaceae) with a conserved type
Nelson Túlio L Pena ... Pedro B Schwartsburd
TAXON | VOL. 72
Nelson Túlio L Pena, et. al.Nelson Túlio L Pena ... Pedro B Schwartsburd
01 Apr 2023
Recasting The Half-Caste
Kumari Jayawardena
Journal of Women's History | VOL. 22
Kumari JayawardenaKumari Jayawardena
01 Dec 2010
View more papers

More From: British Journal of Haematology

Paper Title
Journal
Date
Author
Tyrosine kinase inhibitor maintenance following chimeric antigen receptor T-cell therapy in Philadelphia chromosome-positive acute lymphoblastic leukaemia.
Tamer Othman ... Ibrahim Aldoss
British journal of haematology | VOL. -
Tamer Othman, et. al.Tamer Othman ... Ibrahim Aldoss
29 May 2024
Haematopoietic stem cell transplantation after reduced intensity conditioning in children and adolescents with chronic myeloid leukaemia: A prospective multicentre trial of the I-BFM Study Group.
Herbert Pichler ... Adriana Balduzzi
British journal of haematology | VOL. -
Herbert Pichler, et. al.Herbert Pichler ... Adriana Balduzzi
27 May 2024
Canadian cancer trials group LY.17: A randomized phase II study evaluating novel salvage therapy pre-autologous stem cell transplant in relapsed/refractory diffuse large B-cell lymphoma-outcome of rituximab-dose-intensive cyclophosphamide, etoposide, cisplatin (R-DICEP) versus R-GDP.
Douglas A Stewart ... Michael Crump
British journal of haematology | VOL. -
Douglas A Stewart, et. al.Douglas A Stewart ... Michael Crump
27 May 2024
RUNX1::ETO and CBFβ::MYH11 converge on aberrant activation of BCAT1 to confer a therapeutic vulnerability in core-binding factor-acute myeloid leukaemia.
Siyang Wang ... Kankan Wang
British journal of haematology | VOL. -
Siyang Wang, et. al.Siyang Wang ... Kankan Wang
27 May 2024
View more papers